Fuijifilm’s Early-Stage But Growing Regen Med Unit To Help Hit JPY1 Trillion Target
This article was originally published in Clinica
Fuijifilm is looking to more than double its healthcare sales three years from now and a vital part of the Japanese group’s plan for hitting this ambitious target is to accelerate growth of its emerging pharmaceutical and regenerative medicine segments.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.